Is there a rationale for high-dose chemotherapy as first line treatment of advanced Hodgkin's disease? German Hodgkin's Lymphoma Study Group (GHSG).

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FD8DD413.svg?ark=w1%2F20260515%2FFD8DD413)](https://nobleid.org/work/w1/20260515/FD8DD413)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors